Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases

Safety of bisphosphonates

(2011) Michael Pazianas et al.   BONE

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

(2011) Laura Y. Park-Wyllie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort

(2010) Seo Young Kim et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996-2007

(2010) Zhong Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis

(2010) Bo Abrahamsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

(2010) R. Rizzoli et al.   OSTEOPOROSIS INTERNATIONAL

Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users

(2008) Jeffrey R Curtis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

(2008) B. A. Lenart et al.   OSTEOPOROSIS INTERNATIONAL